Table 3

ST and the risk of HCC in men and women

PatientsOR (95% CI)
Model 1*Model 2†Model 3‡
All men
 Long ST19341 (reference)1 (reference)1(reference)
 Medium ST7560.88 (0.79−0.97)0.88 (0.79−0.97)0.88 (0.79–0.98)
 Short ST10541.04 (0.96−1.13)1.03 (0.95−1.12)1.01 (0.93–1.10)
Stratified by HBV/HCV infection without HBV/HCV infection
 Long ST8681 (reference)1 (reference)1 (reference)
 Medium ST3910.89 (0.77−1.03)0.89 (0.77−1.03)0.89 (0.77–1.03)
 Short ST5350.92 (0.82−1.04)0.92 (0.82−1.04)0.92 (0.81–1.04)
All women
 Long ST5771 (reference)1 (reference)1 (reference)
 Medium ST1420.79 (0.63−0.99)0.78 (0.62−0.98)0.77 (0.62–0.97)
 Short ST2530.97 (0.82−1.15)0.93 (0.79−1.1)0.90 (0.76–1.07)
Stratified by HBV/HCV infection without HBV/HCV infection
 Long ST2551 (reference)1 (reference)1 (reference)
 Medium ST620.71 (0.51−0.99)0.69 (0.49−0.97)0.71 (0.50–0.99)
 Short ST1160.91 (0.71−1.17)0.87 (0.68−1.11)0.86 (0.67–1.10)
  • Values in bold represent statistically significant results (two-sided p < 0.05)

  • *Conditional logistic regression matched for sex, age, admission date and admitting hospital.

  • †Additional adjustment for smoking in Model 1.

  • ‡Additional adjustment for diagnosis of hypertension, type 2 diabetes, dyslipidaemia and obesity in Model 2.

  • HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; ST, sedentary time.